InvestorsHub Logo
Followers 281
Posts 33647
Boards Moderated 1
Alias Born 11/14/2013

Re: None

Monday, 06/13/2016 12:06:44 PM

Monday, June 13, 2016 12:06:44 PM

Post# of 726334

The Company anticipates that the SAB will address a variety of novel issues at the forefront of immuno-oncology, including evaluations of....regulatory strategies (including accelerated pathways) and related matters. -- NWBIO June 13, 2016


Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News